Tag: SHOP

Blue Horseshoe Stocks: AAPL Recap & More

Apple, Inc. AAPL – Recap
–
The recent continual trend of bullish days for the markets ended abruptly yesterday following the Fed’s interest rate cut, however, our AAPL Calls still provided an opportunity for us in the early goings on the session.

We signaled our interest in the AAPL Weekly $215-220 Calls in yesterday morning’s premarket report, and inside the first half hour of trading, the following upward moves were recorded by those three sets of contracts:

AAPL Weekly $215-220 Calls 
$215 Calls – Range: 2.64-6.84 – Max Gain: 60%
$217.50 Calls – Range: 1.57-4.80 – Max Gain: 206%
$220 Calls – Range: .83-3.10  – Max Gain: 273%
____

Fresh Options Ideas: 
AMGN Weekly $185-187.50 Calls
SHOP Weekly $327.50-335 Calls
BYND Weekly $180-170 Puts


T2 Biosystems, Inc. TTOO

We’re always scanning for a good rebound candidate, and that’s what we found in TTOO this morning. The stock is sniffing out a bottom, and has just fallen off of an absolute cliff. Now with a massive gap to the upside and considerable volatility potential, we’re going to begin monitoring it for its ultimate bottom and eventual recovery.

TTOO is egregiously oversold, sitting at an annual low, and could be just days away from a convincing turnaround. We’ll keep our eyes peeled for just such an event.

Extended Watchist: 
RYAM, GEMP, IZEA, PHUN,

Blue Horseshoe Stocks: Form-4 Watchlist, Options Ideas & More

Insider Buying Watchlist

Both of the following are plays that we’ve tracked in some capacity in the past, and each of them grabbed our attention with recent insider transactions of a sizable magnitude which were executed at higher levels than the current PPS. We like to monitor stocks whose directors have confidence in future price performance, and that’s the impression we get when they soak up large blocks of shares in this manner. Each of these stocks is also currently trading at a relative bottom, so we’ll be watching in the days and weeks to come for signs of bounceplay opportunities. 

The ExOne Co.  XONE

In the case of XONE, CEO Kent Rockwell last weekend filed a Form-4 indicating the purchase of a $13M block of XONE at 9.13, more than a dollar per share higher than the current PPS. This is a significant development that warrants heavy monitoring for XONE.

Esperion Therapeutics, Inc. ESPR

The traunch of shares purchased by ESPR director Tim Mayleben wasn’t nearly as large as the previously mentioned block, but still, a $100K investment is nothing at which to sneeze. The trade was executed at 14.08 (Current PPS:13.77). ESPR has just come up off of its newly established 52-week lows, and has been going through a bout of serious under-performance, so we’ll want to keep our heads on a swivel for any developments that might kick this thing into gear.

Fresh Options Ideas

To kick things off this week on the options front, we’ve formulated a couple of ideas based on announced and expected earnings, and the resultant activity we’re observing here in the premarket.

Tiffany & Co. TIF

We’re looking at going bearish on TIF, which, on the heels of a lackluster holiday season in terms of jewelry sales, failed to meet or beat earnings expectations and is currently gapping down in early trading. We’re going to track a range of contracts here, namely the TIF Weekly $66.50-64 Puts, for potential daytrades.

Netflix, Inc. NFLX

NFLX has its earnings call slated for the post-market today, and we’re going to want to track a range of calls in anticipation of that event. We’ve witnessed runs into earnings so many times before, it’d almost be foolish to ignore NFLX under the present circumstances. We’re going to keep an eye on NFLX Weekly $105-107 Calls to take advantage of a possible continued run-up for the stock.

Extended Watchlist:
SBS, AEZS, SHOP, COTE, GDPM, BVAP, PLKD(Bottom-Watch), FREE(1-for-60 Reverse Split)